A team from the University of York has published research unveiling the 3-D structure of human heparanase, a sugar-degrading enzyme which has received significant attention as a key target in anti-cancer treatments.
Though naturally regulated in a healthy organism, heparanase is an enzyme which is produced in excessive quantities in a cancer situation. The sugar-degrading activity of this excess heparanase leads to exaggerated degradation of the sugars in the extracellular 'matrix' (the molecules surrounding cells), making it easier for cancer cells to proliferate.